{"certainAgreement":{"otherDetails":"Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"No analyses of ALK fusion variants or protein expression were done due to limited slide stability of unstained tissue sections required for immunohistochemistry and no nucleic acid based assay was available to identify specific ALK gene fusion."},"pointOfContact":{"email":"ClinicalTrials.gov_Inquiries@pfizer.com","organization":"Pfizer, Inc.","phone":"1-800-718-1021","title":"Pfizer ClinicalTrials.gov Call Center"}}